Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 812-957-9 | CAS number: 333350-60-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Compared to the relative absorbance value of the negative control the mean relative absorbance value was reduced irrelevantly to 93.1% after exposure of the skin tissues to the test item. This value is above the threshold for irritancy of ≤ 50%. Therefore, the test item is not considered to possess an irritant potential.
Relative to the negative control, the test item 4-Methoxy-N-methyl-3-nitrobenzamid did not cause an increase of the corneal opacity and permeability. The calculated mean IVIS was 0.12 (threshold for No Category: IVIS ≤ 3). According to OECD 437 the test item is identified as not requiring classification for eye irritation or serious eye damage i.e. No Category (UN GHS).
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: UN GHS (2003, last rev. 2015)
- Principles of method if other than guideline:
- Based on a “Statement on the Scientific Validity of In Vitro Tests for Skin Irritation” of the European Commission (November 2008), official acceptance of the test method in the EU was achieved and implemented in EU, 2008a, Council Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to EC Regulation No 1907/2006 of the European Parliament and of the Council on REACH; 1st ATP 2009: EC Regulation No 761/2009 of 23 July 2009 amending, for the purpose of its ATP, EC Regulation No 440/2008 laying down test methods pursuant to EC Regulation No 1907/2006 of the European Parliament and of the Council on REACH, section B46.
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 25 mg (~ 39 mg/cm2 according to guideline)
- Duration of treatment / exposure:
- 60 minutes.
- Number of replicates:
- 3
- Species:
- other: reconstituted human epidermis model
- Type of coverage:
- other: Topical
- Preparation of test site:
- other: Not applicable
- Vehicle:
- other: No vehicle used
- Controls:
- yes
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit):
Each approximately 25 mg (~ 39 mg/cm2 according to guideline) of the test item were applied to each tissue, wetted with 25 µL DPBS, and spread to match the surface of the tissue for a complete treatment time of 60 minutes.
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL DPBS (MatTek) were used as negative control per tissue.
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL of a 5% SLS solution in deionised water (MatTek) were used as positive control per tissue.- Duration of treatment / exposure:
- 60 minutes
- Observation period:
- Not applicable
- Number of animals:
- Not applicable
- Irritation / corrosion parameter:
- other: % relative absorbance
- Run / experiment:
- 1
- Value:
- 82.2
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- other: % relative absorbance
- Run / experiment:
- 2
- Value:
- 95
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- other: % relative absorbance
- Run / experiment:
- 3
- Value:
- 102.1
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Interpretation of results:
- other: not irritant
- Conclusions:
- In conclusion, it can be stated that in this study and under the experimental conditions reported, 4-Methoxy-N-methyl-3-nitrobenzamid is not irritant to skin according to UN GHS and EU CLP regulation.
- Executive summary:
This in vitro study was performed to assess the irritation potential of 4-Methoxy-N-methyl-3-nitrobenzamid by means of the Human Skin Model Test.
The test item passed the MTT- and the Colour Interference pre-tests.
Approximately 25 mg of the test item were applied to each tissue, wetted with 25 µL of DPBS, and spread to match the surface of triplicate tissue.
30 µL of either the negative control (DPBS) or the positive control (5% SLS) were applied to triplicate tissue each.
The test item and the positive and negative controls were washed off the skin tissues after 60 minutes treatment. After further incubation for about 43 hours the tissues were treated with the MTT solution for 3 hours following about 3 hours extraction of the colorant from the cells. The amount of extracted colorant was determined photometrically at 570 nm.
After treatment with the negative control the absorbance values were well within the required acceptability criterion of mean OD ≥ 0.8 and ≤ 2.8 for the 60 minutes treatment interval thus showing the quality of the tissues.
Treatment with the positive control induced a decrease in the relative absorbance as compared to the negative control to 3.5% thus ensuring the validity of the test system.
The relative standard deviations between the % variability values of the test item, the positive and negative controls in the main test were below 11% (threshold of the "OECD Guideline for the Testing of Chemicals 439:In vitroSkin Irritation: Reconstructed Human Epidermis Test Method”: < 18%), thus ensuring the validity of the study.
Compared to the relative absorbance value of the negative control the mean relative absorbance value was reduced irrelevantly to 93.1% after exposure of the skin tissues to the test item. This value is above the threshold for irritancy of ≤ 50%. Therefore, the test item is not considered to possess an irritant potential.
Reference
Results after treatment with 4-Methoxy-N-methyl-3-nitrobenzamid and the controls (exposure interval of 60 minutes):
Dose |
Tissue |
Absorbance |
Absorbance |
Absorbance |
Mean |
Mean |
Group |
No. |
570 nm |
570 nm |
570 nm |
Absorbance |
Absorbance |
|
|
Well 1 |
Well 2 |
Well 3 |
of |
of three wells |
|
|
|
|
|
3 Wells |
blank |
|
- |
- |
- |
- |
- |
corrected |
Blank |
- |
0.037 |
0.038 |
0.038 |
0.037 |
0.000 |
Negative Control |
1 |
1.873 |
1.874 |
1.815 |
1.854 |
1.817 |
Negative Control |
2 |
2.080 |
2.059 |
2.045 |
2.062 |
2.024 |
Negative Control |
3 |
1.924 |
1.847 |
1.775 |
1.849 |
1.811 |
Positive Control |
1 |
0.100 |
0.099 |
0.099 |
0.099 |
0.062 |
Positive Control |
2 |
0.099 |
0.108 |
0.109 |
0.105 |
0.068 |
Positive Control |
3 |
0.108 |
0.110 |
0.107 |
0.108 |
0.071 |
Test Item |
1 |
1.535 |
1.601 |
1.620 |
1.585 |
1.535 |
Test Item |
2 |
1.761 |
1.856 |
1.866 |
1.828 |
1.761 |
Test Item |
3 |
1.881 |
2.001 |
2.003 |
1.962 |
1.881 |
Dose |
Tissue |
Mean Absorbance of 3 tissues |
Relative |
Relative |
Mean |
Group |
No. |
after blank |
Absorbance [%] |
Standard |
Relative Absorbance |
|
|
correction* |
Tissue 1, 2, 3 *** |
Deviation |
[% of Negative |
|
|
|
|
[%] |
Control] *** |
Negative Control |
1 |
96.4 |
|||
Negative Control |
2 |
1.884 |
107.4 |
6.4 |
100.0 |
Negative Control |
3 |
96.1 |
|||
Positive Control |
1 |
3.3 |
|||
Positive Control |
2 |
0.067 |
3.6 |
6.8 |
3.5 |
Positive Control |
3 |
3.8 |
|||
Test Item |
1 |
82.2 |
|||
Test Item |
2 |
1.754 |
95.0 |
10.9 |
93.1 |
Test Item |
3 |
102.1 |
* Mean of three replicate wells after blank correction
** relative absorbance per tissue [rounded values]
*** relative absorbance per treatment group [rounded values]
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Deviations:
- no
- Principles of method if other than guideline:
- Bovine Corneal Opacity and Permeability (BCOP) Assay, SOP of Microbiological Associates Ltd., UK, Procedure Details, April 1997.
EC Commission Directive 2004/10/EC - GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- IIdentification: 4-Methoxy-N-methyl-3-nitrobenzamid
Other Name: NASMA
CAS No.: 333350-60-0
Batch: Op 2/16
Purity: 99.5% (w/w), dose calculation was not adjusted to purity
Appearance: Pale yellow powder
Expiry Date: 14.07.2018 (Statement of Sponsor)
Storage Conditions: At room temperature
Certificate of Analysis: AZ 1027/Toxd1, dated 14 July 2016
Stability in Solvent: Not indicated by the Sponsor - Species:
- other: Freshly isolated bovine cornea (at least 9 month old donor cattle)
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- Source: Schlachthof Aschaffenburg, 63739 Aschaffenburg, Germany
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- Amount(s) applied (volume or weight with unit): 0.75 mL
- Duration of treatment / exposure:
- 240 minutes
- Number of animals or in vitro replicates:
- 3 corneae per group (test item, negative control, positive control)
- Details on study design:
- Three corneas were exposed to each 0.75 mL of the test item, the negative, and the positive control for 10 minutes.
SCORING SYSTEM:
Opacity Measurement:
The opacitometer determines changes in the light transmission passing through the corneae, and displays a numerical opacity value. This value was recorded in a table. The opacitometer OP_KiT opacitometer (Electro Design, 63-Riom France) was calibrated as described in the manual and the opacity of each of the corneae was determined by reading each holder placed in the photoreceptor compartment for treated cornea.
After exposure of the corneae to the test groups, after rinsing and further incubation of the corneae for two hours, the opacity value was determined again (t130).
Permeability Determination:
Following the opacity readings, the permeability endpoint was measured as an indication of the integrity of the epithelial cell sheets. After the final opacity measurement was performed, the complete medium was removed from the anterior compartment and replaced by 1 mL of a 0.4% (w/v) sodium fluorescein solution in HBSS. Corneae were incubated again in a horizontal position for 90 minutes in a water-bath at 32 ± 1 °C. Complete medium from the posterior compartment was removed, well mixed and transferred into a 96 well plate and the optical density at 490 nm (OD490) was determined with a spectrophotometer.
The optical density was measured with a microplate reader (Versamax® Molecular Devices) at 490 nm (OD490). The absorbance values were determined using the software SoftMax Pro Enterprise (version 4.7.1).
Data Evaluation
Opacity:
The change of opacity value of each treated cornea or positive and negative control corneae is calculated by subtracting the initial basal opacity from the post treatment opacity reading (t130 – t0).
The average change in opacity of the negative control corneae is calculated and this value is subtracted from the change in opacity of each treated cornea or positive control to obtain a corrected opacity.
Permeability:
The corrected OD490 value of each cornea treated with positive control and test item is calculated by subtracting the average negative control cornea value from the original permeability value for each cornea.
IVIS Calculation:
The following formula is used to determine the IVIS of the negative control:
IVIS = opacity value + (15 x OD490 value)
The following formula is used to determine the IVIS of the positive control and the test item:
IVIS = (opacity value – opacity value mean negative control) + (15 x corrected OD490 value)
The mean IVIS value of each treated group is calculated from the IVIS values.
Depending on the IVIS score obtained, the test item is classified into the following category according to OECD guideline 437:
IVIS UN GHS
≤ 3 No Category
> 3; ≤ 55 No prediction can be made
> 55 Category 1
Criteria for Determination of a Valid Test:
The test will be acceptable if
• the positive control gives an IVIS that falls within two standard deviations of the current historical mean (updated every three months), and if
• the negative control responses result in opacity and permeability values that are less than the established upper limits for background opacity and permeability values for bovine corneae treated with the respective negative control. - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- 1
- Value:
- -0.05
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- in vitro irritation score
- Run / experiment:
- 2
- Value:
- 0.04
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- in vitro irritation score
- Run / experiment:
- 3
- Value:
- 0.36
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritant / corrosive response data:
- Relative to the negative control, the test item 4-Methoxy-N-methyl-3-nitrobenzamid did not cause an increase of the corneal opacity and permeability. The calculated mean IVIS was 0.12 (threshold for No Category: IVIS ≤ 3). According to OECD 437 the test item is identified as not requiring classification for eye irritation or serious eye damage i.e. No Category (UN GHS).
- Other effects:
- None
- Interpretation of results:
- other: According to OECD 437 no prediction can be made whether the test item induces serious eye damage (UN GHS: Category 1) or not (UN GHS: no Category).
- Conclusions:
- In conclusion, according to the current study and under the experimental conditions reported, 4-Methoxy-N-methyl-3-nitrobenzamid is identified as not inducing eye irritation or serious eye damage.
- Executive summary:
This in vitro study was performed to assess the corneal damage potential of 4-Methoxy-N-methyl-3-nitrobenzamidby means of the BCOP assay using fresh bovine corneae.
After a first opacity measurement of the fresh bovine corneae (t0), the 20% (w/v)suspensionin saline of the test item 4-Methoxy-N-methyl-3-nitrobenzamid, the positive, and the negative controls were applied to corneae and incubated for 240 minutes at 32± 1 °C. After the incubation phase the test item, the positive, and the negative controls were each rinsed from the corneae andopacity was measured again (t240).
After the opacity measurements permeability of the corneae was determined by measuring spectrophotometrically the transfer of sodium fluorescein after incubation in a horizontal position for 90 minutes at 32 ± 1 °C.
With the negative control (saline) neither an increase of opacity nor permeability of the corneae could be observed (mean IVIS = 0.82).
The positive control (10% (w/v) Benzalkonium chloride in saline) showed clear opacity and distinctive permeability of the corneae (mean IVIS =107.73)corresponding to a classification as “Causes serious eye damage” (CLP/EPA/GHS (Cat 1)).
Relative to the negative control, the test item 4-Methoxy-N-methyl-3-nitrobenzamid did not cause an increase of the corneal opacity and permeability. The calculated mean IVIS was 0.12 (threshold for No Category: IVIS ≤ 3). According to OECD 437 the test item is identified as not requiring classification for eye irritation or serious eye damage i.e. No Category (UN GHS).
Reference
Results after 240 Minutes Incubation Time
Test Group |
Opacity value = Difference (t240-t0) of Opacity |
|
Permeability |
|
IVIS |
Mean IVIS |
Proposed UN GHS Category |
|
|
Mean |
|
Mean |
|
|
|
Negative Control |
0 |
|
0.055 |
|
0.83 |
|
|
|
0 |
0.00 |
0.052 |
0.054 |
0.78 |
0.82 |
No Category |
|
0 |
|
0.056 |
|
0.84 |
|
|
Positive Control |
118.00* |
|
0.323* |
|
122.84 |
|
|
|
100.00* |
|
0.110* |
|
101.65 |
107.73 |
Category 1 |
|
98.00* |
|
0.047* |
|
98.70 |
|
|
4-Methoxy-N-methyl-3-nitrobenz-amid |
0.00* |
|
-0.003* |
|
-0.05 |
|
|
|
0.00* |
|
0.003* |
|
0.04 |
0.12 |
No Category |
|
0.00* |
|
0.024* |
|
0.36 |
|
|
*corrected values
*corrected values
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
No Classification
No irritant effects were recorded in a human skin model as well as in a bovine cornal apocity test (BCOP)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.